Marvel Biosciences Announces Testing MB-204 on Autism by French University

Marvel Biosciences Corp. and its wholly owned subsidiary, Marvel Biotechnology Inc. , is pleased to announce it has begun testing MB-204 in the Oprm1 mouse model of autism in collaboration with Dr....

Related Keywords

France ,Mark Williams ,Julie Le Merrer ,Jerome Becker ,Regulation Services Provider ,Marvel Biosciences Corp ,Venture Exchange ,Brain Institute ,Company Or Marvel ,Alberta Newsfile Corp ,Marvel Biotechnology Inc ,Marvel Biotechnology ,Rod Matheson ,Biosciences Corp ,Chief Executive Officer ,Chief Science ,